Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anniina Luostarinen"'
Autor:
Dominik Mumberg, Anniina Luostarinen, Mari I. Suominen, Jenni H. Mäki-Jouppila, Katja M. Fagerlund, Birgitta Sjöholm, Jukka P. Rissanen, Sanna-Maria Käkönen, Gerhard Siemeister, Arne Scholz, Anna Huhtinen, Esa Alhoniemi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 5570, p 5570 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 11
International Journal of Molecular Sciences
Volume 22
Issue 11
Osteolytic bone disease is a hallmark of multiple myeloma (MM) mediated by MM cell proliferation, increased osteoclast activity, and suppressed osteoblast function. The proteasome inhibitor bortezomib targets MM cells and improves bone health in MM p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc64c584fab49eaba12f8fc70a0b90a4
https://www.mdpi.com/1422-0067/22/11/5570
https://www.mdpi.com/1422-0067/22/11/5570
Autor:
Dominik Mumberg, Sanna-Maria Käkönen, Jussi M. Halleen, Jukka P. Rissanen, Birgitta Sjöholm, Mari I. Suominen, Arne Scholz, Esa Alhoniemi, Karl Ziegelbauer, Katja M. Fagerlund, Anniina Luostarinen
Publikováno v:
Cancer Research. 77:5202-5202
Radium-223 dichloride (radium-223, Xofigo®), a targeted alpha-therapy, improves overall survival in prostate cancer patients with bone metastases. It inhibits disease progression by reducing tumor growth and tumor-induced pathological bone reaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::632aa0f0158a604ef6a64909ea16788a
https://doi.org/10.1158/1538-7445.am2017-5202
https://doi.org/10.1158/1538-7445.am2017-5202